Physician profile
Meredith E Clement
NPI 1982994588
$92,503.58
in general payments reported to CMS, 2019-2025
5 companies · $28K in 2025
The $28K reported for 2025 was more than what 97% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $2,400 · 2021: $1,955 · 2022: $29.44 · 2023: $18K · 2024: $41K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $19K · Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,831.80 |
| Travel and Lodging | $18,820.93 |
| Food and Beverage | $1,348.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $54,422.87 | 2021-2025 | Apretude, Cabenuva |
| Gilead Sciences, INC. | $32,182.92 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $3,497.79 | 2025 | |
| Roche Diagnostics Corporation | $2,400.00 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Clement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.